MARKET

RVPHW

RVPHW

Reviva Pharmaceutcls Hldgs Inc
NASDAQ
0.0540
+0.0004
+0.75%
Closed 15:17 04/17 EDT
OPEN
0.0401
PREV CLOSE
0.0536
HIGH
0.0544
LOW
0.0401
VOLUME
36.78K
TURNOVER
--
52 WEEK HIGH
0.7800
52 WEEK LOW
0.0226
MARKET CAP
--
P/E (TTM)
-0.0598
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RVPHW last week (0407-0411)?
Weekly Report · 4d ago
REVIVA PHARMACEUTICALS HOLDINGS INC <RVPH.O>: BENCHMARK CUTS TARGET PRICE TO $14 FROM $17
Reuters · 04/09 11:29
Weekly Report: what happened at RVPHW last week (0331-0404)?
Weekly Report · 04/07 09:39
REVIVA PHARMACEUTICALS: EXPECTS TO REPORT MATERIAL WEAKNESSES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
Reuters · 03/31 21:18
REVIVA PHARMACEUTICALS HOLDINGS FILES FOR NON-TIMELY 10-K - SEC FILING
Reuters · 03/31 21:18
BRIEF-Reviva Pharmaceuticals FY EPS USD -0.9
Reuters · 03/31 20:06
REVIVA REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
Reuters · 03/31 20:05
Weekly Report: what happened at RVPHW last week (0324-0328)?
Weekly Report · 03/31 09:42
More
About RVPHW
More
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, respiratory and metabolic diseases. Its pipeline includes two drug candidates, RP5063 (brilaroxazine) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).
Recently
Symbol
Price
%Change

Webull offers Reviva Pharmaceuticals Holdings, Inc. stock information, including NASDAQ: RVPHW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPHW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPHW stock methods without spending real money on the virtual paper trading platform.